about
Protein kinase C signaling and cell cycle regulationBalancing Inflammation: The Link between Th17 and Regulatory T CellsmTOR Regulation of Lymphoid Cells in Immunity to PathogensGlucose Metabolism in T Cells and Monocytes: New Perspectives in HIV PathogenesisFinding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging MoleculesInhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and BeyondRegulation of IL-10 and IL-12 production and function in macrophages and dendritic cellsIL-15-PI3K-AKT-mTOR: A Critical Pathway in the Life Journey of Natural Killer CellsMetabolic regulation of regulatory T cell development and functionMicroRNA regulation of lymphocyte tolerance and autoimmunityPrimer on tumor immunology and cancer immunotherapyTranscriptional regulation of the NKT cell lineageInterleukin-6 secretion by astrocytes is dynamically regulated by PI3K-mTOR-calcium signalingCytosolic branched chain aminotransferase (BCATc) regulates mTORC1 signaling and glycolytic metabolism in CD4+ T cellsSignaling by the phosphoinositide 3-kinase family in immune cellsZika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus MonkeysPI3K and cancer: lessons, challenges and opportunitiesThe kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.The spleen in liver cirrhosis: revisiting an old enemy with novel targets.Staphylococcus aureus alpha-toxin mediates general and cell type-specific changes in metabolite concentrations of immortalized human airway epithelial cells.Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation.Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy.Lactic acid bacteria-specific induction of CD4+Foxp3+T cells ameliorates shrimp tropomyosin-induced allergic response in mice via suppression of mTOR signaling.Proliferation conditions promote intrinsic changes in NK cells for an IL-10 response.Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.Regulation of blood-testis barrier (BTB) dynamics during spermatogenesis via the "Yin" and "Yang" effects of mammalian target of rapamycin complex 1 (mTORC1) and mTORC2.Epithelial cell specific Raptor is required for initiation of type 2 mucosal immunity in small intestineDifferential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cellsp38 signaling inhibits mTORC1-independent autophagy in senescent human CD8⁺ T cells.Indoleamine 2,3 dioxygenase and metabolic control of immune responses.Adenosine triphosphate-competitive mTOR inhibitors: a new class of immunosuppressive agents that inhibit allograft rejectionmTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function.The battle over mTOR: an emerging theatre in host-pathogen immunityInsight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection.Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system.Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond.mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition.The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex.The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection
P2860
Q21131217-DDD0AC1F-7BBF-4C52-A8A4-0E710819F56EQ26740440-B2754A83-7B7C-489F-A61E-449FF27E2DFCQ26744649-89BD7391-FFDE-4033-A6A8-F3CED5C634C4Q26747110-56406E47-4091-402E-BE3E-6491A48937EAQ26747742-090260F5-45D5-4B48-82EE-8FCDF69D51D3Q26751462-8ACC9AD2-DCA3-401F-9B86-822422FCC268Q26766184-26C2378C-C5C9-4222-9D94-1C2A4BDC7E90Q26800159-83E0F6C0-F45D-4B91-AFFC-2E4566AAB723Q26852681-B050D7AA-028A-4AFC-B5D6-56B9FF40F446Q26852975-8B672F1F-F592-4D6D-A00C-3CD457811F01Q27001126-C0E09CF2-EC88-4873-8E60-AB02786D6393Q27012749-3651A1BF-5032-4BF1-A3C0-2F29AA29F714Q27313777-FEEBDD65-FE3D-49E7-8803-FAD8969E5B14Q28240491-F24AC6F9-B39C-4E0B-8B8B-45DFF458620DQ28283677-0250D322-4557-4053-B01A-CB38D7780EBFQ29587262-2634B21B-6E25-496E-B4F0-B400F72D4F7AQ30080017-4F6DF17F-AFDD-4D51-906B-47BD0D89E85CQ30354732-17CB1E94-37F0-4AE5-AE4C-0F78E7E1798CQ30355782-9CB1598A-C4CC-44FB-9CEE-162E1628B6B0Q30440120-203B0232-3AA8-4BB9-83FC-09A8286A5863Q33584702-108C2C07-7E1E-476F-9959-902C459B1ABEQ33665207-BC62E4B6-787F-4B43-844F-36E748B1B360Q33694810-6608D28B-D90B-4944-A03C-84E2859FB181Q33787389-337C8688-C328-4415-A4F3-17CDE196EFD4Q33804736-E6EC821B-D632-4DA8-8037-8AAEB919BA6DQ33839054-670CA9DD-BE43-4866-8080-7BDDA916B977Q33863571-CE06AD80-201F-4412-AFE6-4A6803888D06Q33912201-1CA22CA1-C1F3-443C-8B6D-49E090C43490Q34103945-2697DB88-3971-4FBF-B599-51BA70E6E345Q34117494-DA21E15A-0852-4599-9FAC-A262FCB797D6Q34308495-97C8C334-C24E-4CAF-86E1-C8A2C206CA95Q34337228-21A6AEA6-B300-4916-B2FC-5BEC033FD6F0Q34364808-5E8E97D7-EB6C-4E9A-9DD1-F2DD492428E5Q34426431-225D7353-1604-47F3-8696-FD435DA20DD6Q34437449-5C2547FA-5D04-49C7-B57A-93AE73B39D61Q34497857-023E5854-7DC8-4D01-B2CE-846729D9D43DQ34534303-A9859750-C190-4618-AF83-C3F44AB36A6CQ34601734-C6FD3C6D-DBAC-48B1-BDC5-3EBBC02067A9Q34712316-C4E0B0F5-2D73-4610-90D7-C0C213C8A683Q34734469-73F7E6D8-B709-44B0-91FE-FF9CB0A3D628
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Regulation of immune responses by mTOR.
@en
Regulation of immune responses by mTOR.
@nl
type
label
Regulation of immune responses by mTOR.
@en
Regulation of immune responses by mTOR.
@nl
prefLabel
Regulation of immune responses by mTOR.
@en
Regulation of immune responses by mTOR.
@nl
P2093
P2860
P1476
Regulation of immune responses by mTOR.
@en
P2093
Jonathan D Powell
Kristen N Pollizzi
Maureen R Horton
P2860
P356
10.1146/ANNUREV-IMMUNOL-020711-075024
P577
2011-11-29T00:00:00Z